MammaPrint

An in vitro molecular diagnostic test that uses gene expression profiling to analyze gene activity within a breast cancer tumor sample. It looks at… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2017
0102020052017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND The 70-gene signature test (MammaPrint) has been shown to improve prediction of clinical outcome in women with early… (More)
  • table 1
  • table 1
  • table 2
  • figure 3
Is this relevant?
2014
2014
MammaPrint, a prognostic 70-gene profile for early-stage breast cancer, has been available for fresh tissue. Improvements in RNA… (More)
Is this relevant?
2014
2014
AIM To measure the impact of MammaPrint on adjuvant treatment decisions and to analyze the agreement in treatment decisions… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Gene expression data from microarrays are being applied to predict preclinical and clinical endpoints, but the reliability of… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?
2010
2010
BACKGROUND MammaPrint was developed as a diagnostic tool to predict risk of breast cancer metastasis using the expression of 70… (More)
  • figure 1
  • table 1
  • table 1
  • table 1
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Optimizing treatment through microarray-based molecular subtyping is a promising method to address the problem of heterogeneity… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Multigene assays have been developed and validated to determine the prognosis of breast cancer. In this study, we assessed the… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
2009
2009
Mammographic screening and increased awareness has led to an increase in the detection of T1 breast tumors that are generally… (More)
  • table 1
  • figure 2
  • table 2
Is this relevant?
2008
2008
PURPOSE Most node-negative breast cancer patients are older and postmenopausal and are increasingly being offered adjuvant… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
A 70-gene tumor expression profile was established as a powerful predictor of disease outcome in young breast cancer patients… (More)
Is this relevant?